Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Kossan Rubber Industries Bhd (7153.KL)
Shah Alam, MY
Kossan Rubber Industries Bhd functions as an investment holding entity primarily engaged in the production and global distribution of latex disposable gloves. The company's diverse operations are organized into four key divisions: Technical Rubber Products, Gloves, Cleanroom Products, and Others. Kossan provides an extensive array of engineered rubber products, encompassing marine dock fenders, high damping and elastomeric bearings, expansion joints, panels, liners, mechanical pot bearings, floating slab track bearings, lateral bearings, and rubber wedges. It also manufactures EVA products, predominantly serving the footwear sector. The company's offerings extend to custom extruded products and profiles, including pressure sensors, solid and sponge extrusions, structural insulation, and insulator profiles. These products find applications across various domains such as domestic use, construction, civil engineering, electrical appliances, industrial machinery, and automotive components. Additionally, Kossan produces molded rubber products for automotive, pipe seal, gasket, and general industrial applications. It supplies rubber rolls crucial for processes like printing, transferring, coating, laminating, coiling, beading, creasing, pressure application, slitting, and winding. Its polyurethane (PU) product line features PU rollers, precision PU articles, and PU tubing sleeves and rods. A significant part of its business involves manufacturing natural rubber latex, nitrile, and rubber latex surgical and procedure gloves for the healthcare, specialty, and cleanroom industries, marketed under the Puresafe, Chemax, and 7th Sense brands. The company also supplies cleanroom facemasks, gloves, and wipes, alongside various industrial personal protective equipment. Beyond manufacturing, Kossan is involved in machinery fabrication and installation, the production, processing, and trading of chemicals and rubber compounds, distribution services, and property holding. Incorporated in 1979, Kossan Rubber Industries Bhd is headquartered in Klang, Malaysia.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.67% | -3.17% | +12.96% | +19.61% | +11.93% | +11.93% | -26.51% | -17.57% | -70.10% | -26.95% | +1,294.29% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 7 | 0 |
| Hold | 4 | 0 |
| Sell | 2 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Instruments & Supplies: +7.9%-8.3% Q1'26: -3.5% (vs Q1'25)
-
EPS growth Medical - Instruments & Supplies: +16.3%+27.2% ★ Q1'26: -100.0% (vs Q1'25)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%+14.4% ★ Q1'26: +17.7% (vs Q1'25)
-
EBIT margin Medical - Instruments & Supplies: +13.5%+7.6% Q1'26: +9.8% (vs Q1'25)
-
ROIC Medical - Instruments & Supplies: +6.0%+5.2% Q1'26: +7.5% (vs Q1'25)
-
Share dilution Medical - Instruments & Supplies: +0.1%-0.9% ★ Q1'26: -100.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×0.27× ★ Q1'26: 0.11× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 14 Rev. Ana. 13 EPS Ana. |
Dec 2027 14 Rev. Ana. 13 EPS Ana. |
Dec 2028 6 Rev. Ana. 9 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.64B
est: 1.68B (-2.2%)
|
1.67B
est: 1.77B (-5.8%)
|
1.96B
est: 1.95B (+0.1%)
|
2.14B
est: 2.11B (+1.4%)
|
2.22B
est: 2.32B (-4.3%)
|
3.64B
est: 4.08B (-10.9%)
|
6.63B
est: 7.17B (-7.5%)
|
2.34B
est: 2.38B (-1.5%)
|
1.59B
est: 1.65B (-3.4%)
|
1.91B
est: 2.00B (-4.6%)
|
1.75B
est: 1.94B (-9.8%)
|
1.98B
1.73B – 2.58B
+2.2% YoY
|
2.12B
1.79B – 2.78B
+7.1% YoY
|
2.19B
1.88B – 2.86B
+3.2% YoY
|
| EBITDA |
345.63M
est: 468.65M (-26.2%)
|
289.38M
est: 494.82M (-41.5%)
|
312.89M
est: 546.31M (-42.7%)
|
345.58M
est: 589.66M (-41.4%)
|
387.68M
est: 647.24M (-40.1%)
|
1.57B
est: 1.14B (+37.6%)
|
3.88B
est: 2.00B (+93.4%)
|
347.84M
est: 664.65M (-47.7%)
|
148.90M
est: 460.52M (-67.7%)
|
265.93M
est: 438.97M (-39.4%)
|
232.12M
est: 425.79M (-45.5%)
|
434.96M
379.49M – 567.27M
+2.2% YoY
|
465.68M
394.16M – 609.98M
+7.1% YoY
|
480.52M
412.76M – 628.10M
+3.2% YoY
|
| EBIT |
278.72M
est: 390.97M (-28.7%)
|
220.04M
est: 412.80M (-46.7%)
|
239.64M
est: 455.76M (-47.4%)
|
268.77M
est: 491.93M (-45.4%)
|
291.94M
est: 539.96M (-45.9%)
|
1.46B
est: 951.88M (+53.0%)
|
3.76B
est: 1.67B (+124.7%)
|
217.78M
est: 554.48M (-60.7%)
|
35.95M
est: 384.19M (-90.6%)
|
159.41M
est: 336.01M (-52.6%)
|
131.97M
est: 325.92M (-59.5%)
|
332.94M
290.48M – 434.22M
+2.2% YoY
|
356.46M
301.71M – 466.91M
+7.1% YoY
|
367.82M
315.95M – 480.78M
+3.2% YoY
|
| Net Income |
202.53M
est: 212.45M (-4.7%)
|
167.06M
est: 178.53M (-6.4%)
|
182.06M
est: 183.98M (-1.0%)
|
199.77M
est: 203.25M (-1.7%)
|
224.65M
est: 225.90M (-0.6%)
|
1.09B
est: 1.07B (+1.6%)
|
2.85B
est: 3.05B (-6.4%)
|
157.10M
est: 168.68M (-6.9%)
|
13.34M
est: 44.99M (-70.4%)
|
120.03M
est: 120.50M (-0.4%)
|
151.31M
est: 132.45M (+14.2%)
|
153.51M
116.95M – 192.92M
+15.9% YoY
|
171.57M
122.22M – 223.77M
+11.8% YoY
|
182.28M
148.86M – 255.04M
+6.2% YoY
|
| SGA |
225.72M
est: 134.81M (+67.4%)
|
206.02M
est: 142.34M (+44.7%)
|
261.86M
est: 157.15M (+66.6%)
|
322.20M
est: 169.62M (+90.0%)
|
217.74M
est: 186.19M (+16.9%)
|
266.71M
est: 328.22M (-18.7%)
|
370.62M
est: 576.34M (-35.7%)
|
297.30M
est: 191.19M (+55.5%)
|
—
est: 132.47M (-100.0%)
|
278.24M
est: 131.32M (+111.9%)
|
—
est: 127.38M (-100.0%)
|
130.12M
113.52M – 169.70M
+2.2% YoY
|
139.31M
117.91M – 182.48M
+7.1% YoY
|
143.75M
123.48M – 187.90M
+3.2% YoY
|
| EPS |
0.08
est: 0.08 (-4.9%)
|
0.07
est: 0.07 (-6.7%)
|
0.07
est: 0.07 (-1.3%)
|
0.08
est: 0.08 (-2.0%)
|
0.09
est: 0.09 (-0.8%)
|
0.43
est: 0.42 (+2.6%)
|
1.12
est: 1.20 (-6.3%)
|
0.06
est: 0.07 (-6.8%)
|
0.01
est: 0.02 (-70.5%)
|
0.05
est: 0.05 (-1.4%)
|
0.06
est: 0.05 (+14.2%)
|
0.06
0.05 – 0.08
+15.9% YoY
|
0.07
0.05 – 0.09
+11.8% YoY
|
0.07
0.06 – 0.10
+6.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-21 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-20 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-19 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-18 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-15 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-14 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-13 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-12 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-11 | A | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-08 | A | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-07 | A | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-06 | A | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-05 | A | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-04 | A | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-04-30 | A- | 4/5 | 4/5 | 2/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-04-29 | A- | 4/5 | 4/5 | 2/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-04-28 | A- | 4/5 | 4/5 | 2/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-04-27 | A- | 4/5 | 4/5 | 2/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 2/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 2/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 2/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 2/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-17 | A- | 4/5 | 4/5 | 2/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 2/5 | 5/5 | 2/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF ISFE.L | 0.03% | 22.5K | 0.74% |
| 2 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.03% | 33.7K | 0.42% |
| 3 | iShares MSCI Emerging Markets Small-Cap ETF EEMS | 0.03% | 97.3K | 0.72% |
| 4 | iShares MSCI EM Small Cap UCITS ETF IEMS.L | 0.02% | 61.5K | 0.74% |
| 5 | State Street SPDR MSCI Emerging Markets Small Cap UCITS ETF EMSD.L | 0.02% | 91.4K | 0.55% |
| 6 | Dimensional - Emerging Markets Value ETF DFEV | 0.01% | 221.0K | 0.46% |
| 7 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.01% | 1.40M | 0.06% |
| 8 | Avantis Emerging Markets ex-China Equity ETF AVXC | 0.01% | 32.2K | 0.33% |
| 9 | Avantis Responsible Emerging Markets Equity ETF AVSE | 0.01% | 14.8K | 0.33% |
| 10 | Dimensional - Emerging Markets ex China Core Equity ETF DEXC | 0.01% | 21.3K | 0.56% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Siau Tian Lim | Executive Director of Marketing - Gloves Division & Non-Independent Executive Director | 266.0K | male |
| Kong Chang Tan | Chief Operating Officer of Glove Division, Executive Director of Human Resources & Non-Independent Executive Director | 262.0K | male |
| Ooi Chow Lim | Executive Director of Engineering & Non-Independent Executive Director | 235.0K | male |
| Kuang Sia Lim | Group MD, Chief Executive Officer & Non-Independent Executive Director | 2.0K | male |
| Ong Leong Chia | Company Secretary | — | male |
| Tan Teng Or | Chief Operations Officer of TRP Division - Infrastructure | — | — |
| Benjamin Wynn Lim | Investor Relation Officer | — | — |
| Yew Ngo Chia | Company Secretary | — | male |
| Chee Hong Mok | Chief Financial Officer | — | male |
| Chee Lee | Senior Group Accountant | — | male |
| Cheng Moey Chow | Chief Financial Controller | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 7153.KL
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
